Back
Results - Announcements
Sales rise 111.67% to Rs 33.38 crore
Indo US Bio-Tech standalone net profit rises 607.69% in the March 2025 quarter
27-May-2025, 07:37
Net profit of Indo US Bio-Tech rose 607.69% to Rs 3.68 crore in the quarter ended March 2025 as against Rs 0.52 crore during the previous quarter ended March 2024. Sales rose 111.67% to Rs 33.38 crore in the quarter ended March 2025 as against Rs 15.77 crore during the previous quarter ended March 2024.
Net profit of Indo US Bio-Tech rose 607.69% to Rs 3.68 crore in the quarter ended March 2025 as against Rs 0.52 crore during the previous quarter ended March 2024. Sales rose 111.67% to Rs 33.38 crore in the quarter ended March 2025 as against Rs 15.77 crore during the previous quarter ended March 2024.
For the full year,net profit rose 97.45% to Rs 16.27 crore in the year ended March 2025 as against Rs 8.24 crore during the previous year ended March 2024. Sales rose 42.56% to Rs 103.84 crore in the year ended March 2025 as against Rs 72.84 crore during the previous year ended March 2024.
Particulars | Quarter Ended | Year Ended | ||||
Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
Sales | 33.38 | 15.77 | 112 | 103.84 | 72.84 | 43 |
OPM % | 13.69 | 6.21 | - | 18.24 | 14.81 | - |
PBDT | 4.43 | 0.83 | 434 | 17.63 | 9.60 | 84 |
PBT | 3.87 | 0.63 | 514 | 16.53 | 8.80 | 88 |
NP | 3.68 | 0.52 | 608 | 16.27 | 8.24 | 97 |
Powered by Capital Market - Live News